The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study

Loo, A.J.A.E. van de; Bervoets, A.C.; Mooren, L.; Bouwmeester, N.H.; Garssen, J.; Zuiker, R.; ... ; Verster, J.C. (2017)

Article / Letter to editor

• Driving
• SDLP
• Esketamine
• Mirtazapine
• Depression

• All authors: Loo, A.J.A.E. van de; Bervoets, A.C.; Mooren, L.; Bouwmeester, N.H.; Garssen, J.; Zuiker, R.; Amerongen, G. van; Gerven, J. van; Singh, J.; Ark, P. van der; Fedgchin, M.; Morrison, R.; Wajs, E.; Verster, J.C.
• Date: 2017-11-30
• Journal: Psychopharmacology
• Volume: 234
• Issue: 21
• Pages: 3175 - 3183
• DOI: doi:10.1007/s00213-017-4706-6